- Home
- VNDA vs DMRC Comparison
VNDA vs DMRC Comparison
Compare VNDA & DMRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNDA
- DMRC
- Stock Information
- Founded
- VNDA 2002
- DMRC 2008
- Country
- VNDA United States
- DMRC United States
- Employees
- VNDA N/A
- DMRC N/A
- Industry
- VNDA Biotechnology: Pharmaceutical Preparations
- DMRC EDP Services
- Sector
- VNDA Health Care
- DMRC Technology
- Exchange
- VNDA Nasdaq
- DMRC Nasdaq
- Market Cap
- VNDA 237.9M
- DMRC 279.8M
- IPO Year
- VNDA 2006
- DMRC N/A
- Fundamental
- Price
- VNDA $3.95
- DMRC $12.62
- Analyst Decision
- VNDA Strong Buy
- DMRC Buy
- Analyst Count
- VNDA 2
- DMRC 2
- Target Price
- VNDA $16.50
- DMRC $30.00
- AVG Volume (30 Days)
- VNDA 471.1K
- DMRC 204.0K
- Earning Date
- VNDA 05-07-2025
- DMRC 05-05-2025
- Dividend Yield
- VNDA N/A
- DMRC N/A
- EPS Growth
- VNDA N/A
- DMRC N/A
- EPS
- VNDA N/A
- DMRC N/A
- Revenue
- VNDA $201,351,000.00
- DMRC $37,848,000.00
- Revenue This Year
- VNDA $14.36
- DMRC N/A
- Revenue Next Year
- VNDA $44.53
- DMRC N/A
- P/E Ratio
- VNDA N/A
- DMRC N/A
- Revenue Growth
- VNDA 13.37
- DMRC 2.44
- 52 Week Low
- VNDA $3.85
- DMRC $10.44
- 52 Week High
- VNDA $6.75
- DMRC $48.32
- Technical
- Relative Strength Index (RSI)
- VNDA 33.16
- DMRC 44.89
- Support Level
- VNDA $4.20
- DMRC $11.76
- Resistance Level
- VNDA $4.51
- DMRC $14.27
- Average True Range (ATR)
- VNDA 0.18
- DMRC 0.84
- MACD
- VNDA -0.02
- DMRC 0.25
- Stochastic Oscillator
- VNDA 1.43
- DMRC 46.25
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.
About DMRC Digimarc Corporation
Digimarc Corp is engaged in digital watermarking technologies. The Digimarc Illuminate platform is a distinctive software as a service (SaaS) cloud-based platform for digital connectivity that provides the tools for the application of digital watermarks and dynamic Quick Response (QR) codes, software (digital twins) that enables various systems and devices to interact with those data carriers, and a centralized platform for capturing insights about digital interactions and automating activities based on that information. The company generates revenue through commercial and government applications of its technology. The company derives its revenue from software development services, subscriptions for products and related services, and licensing of patents.